Somerset Indus Capital Partners, a provider of private equity and equity-related investments, completed the acquisition of a minority stake in Emil Pharmaceuticals, is a company responisble for creating, producing, and selling medications of a quality that is recognised worldwide. Financial terms were not disclosed.